Live Quote · NASDAQDYNHealthcare· Biotechnology

Dyne Therapeutics, Inc.

$15.50▼ 3.31%($-0.53)
MKT CAP $2.90BNEXT EARNINGS Mar 1, 2027
50%
Bullish
TickerSpark Score
41/100
▌ Weak
53
Valuation
20
Profitability
20
Growth
84
Health
30
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a DYN research report →

Analyst Price Target
$36.88+137.9% vs. today

Range $26 – $50

Analyst RatingBuy
11 Buy2 Hold1 Sell

Price Chart

-22.18% · this period
$26.78$20.52$14.25Nov 19May 22Nov 19
52-Week Range11% of range
Low
$14.00
Current
$15.50
High
$27.31